Avicanna Applauds President Trump's Executive Order to Reclassify Cannabis & Provides Scientific Update
Avicanna's evidence-based pathway for cannabinoid-based medicine aligns with the executive order. Avicanna's 2025 advances across R&D, clinical development, and medical affairs. TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. ("Avicanna" or the "Compa
(Financial Post, 2025-12-19T12:32:23Z)